SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-Sep-24 1:40 PM View: | Volcon, Inc. (VLCN) | 30-Aug-24 | Private Purchase | 10,000 | $1.42 | $14,156.00 | 1% 764.57K to 774.57K | |
30-Aug-24 5:07 PM View: | Volcon, Inc. (VLCN) | 29-Aug-24 | Purchase | 3,064 | $1.45 | $4,442.80 | < 1% 761.5K to 764.57K | |
30-Aug-24 5:07 PM View: | Volcon, Inc. (VLCN) | 28-Aug-24 | Private Purchase | 21,998 | $1.50 | $32,906.80 | 3% 739.51K to 761.5K | |
28-Aug-24 10:15 AM View: | Volcon, Inc. (VLCN) | 26-Aug-24 | Private Purchase | 3,194 | $1.55 | $4,936.01 | < 1% 736.31K to 739.51K | |
26-Aug-24 12:25 PM View: | Volcon, Inc. (VLCN) | 23-Aug-24 | Purchase | 3,500 | $1.55 | $5,419.40 | < 1% 732.81K to 736.31K | |
26-Aug-24 12:25 PM View: | Volcon, Inc. (VLCN) | 22-Aug-24 | Private Purchase | 3,598 | $1.49 | $5,350.95 | < 1% 762.01K to 765.61K | |
26-Aug-24 12:25 PM View: | Volcon, Inc. (VLCN) | 22-Aug-24 | Sale | 32,794 | $2.05 | $67,227.70 | (4%) 765.61K to 732.81K | |
22-Aug-24 11:30 AM View: | Volcon, Inc. (VLCN) | 21-Aug-24 | Purchase | 17,757 | $1.50 | $26,676.30 | 2% 744.25K to 762.01K | |
22-Aug-24 11:30 AM View: | Volcon, Inc. (VLCN) | 20-Aug-24 | Private Purchase | 10,953 | $1.57 | $17,163.40 | 1% 733.3K to 744.25K | |
20-Aug-24 10:05 AM View: | Volcon, Inc. (VLCN) | 19-Aug-24 | Purchase | 5,065 | $1.59 | $8,076.65 | < 1% 728.23K to 733.3K | |
20-Aug-24 10:05 AM View: | Volcon, Inc. (VLCN) | 16-Aug-24 | Private Purchase | 16,974 | $1.43 | $24,347.50 | 2% 711.26K to 728.23K | |
16-Aug-24 8:29 AM View: | Volcon, Inc. (VLCN) | 15-Aug-24 | Purchase | 27,514 | $1.51 | $41,529.60 | 4% 683.75K to 711.26K | |
16-Aug-24 8:29 AM View: | Volcon, Inc. (VLCN) | 14-Aug-24 | Private Purchase | 20,158 | $1.62 | $32,641.80 | 3% 663.59K to 683.75K | |
14-Aug-24 10:23 AM View: | Volcon, Inc. (VLCN) | 13-Aug-24 | Purchase | 3,372 | $1.68 | $5,663.27 | < 1% 660.22K to 663.59K | |
14-Aug-24 10:23 AM View: | Volcon, Inc. (VLCN) | 12-Aug-24 | Private Purchase | 6,087 | $1.64 | $9,995.46 | < 1% 654.13K to 660.22K | |
12-Aug-24 11:14 AM View: | Volcon, Inc. (VLCN) | 09-Aug-24 | Purchase | 7,116 | $1.64 | $11,702.30 | 1% 647.01K to 654.13K | |
12-Aug-24 11:14 AM View: | Volcon, Inc. (VLCN) | 08-Aug-24 | Private Purchase | 8,019 | $1.65 | $13,226.50 | 1% 638.99K to 647.01K | |
08-Aug-24 9:22 AM View: | Volcon, Inc. (VLCN) | 07-Aug-24 | Purchase | 43,756 | $1.76 | $76,826.80 | 7% 595.24K to 638.99K | |
08-Aug-24 9:22 AM View: | Volcon, Inc. (VLCN) | 06-Aug-24 | Private Purchase | 3,284 | $1.82 | $5,978.85 | < 1% 592.47K to 595.75K | |
08-Aug-24 9:22 AM View: | Volcon, Inc. (VLCN) | 06-Aug-24 | Sale | 512 | $2.05 | $1,049.96 | (< 1%) 595.75K to 595.24K | |
06-Aug-24 1:09 PM View: | Volcon, Inc. (VLCN) | 05-Aug-24 | Purchase | 74,574 | $1.81 | $134,957.00 | 14% 517.89K to 592.47K | |
06-Aug-24 1:09 PM View: | Volcon, Inc. (VLCN) | 02-Aug-24 | Private Purchase | 40,349 | $1.94 | $78,450.60 | 8% 477.54K to 517.89K | |
04-Feb-19 1:35 PM View: | EnteroMedics, Inc. (RSLS) | 01-Feb-19 | Purchase | 1,192,000 | -- | -- | (100%) 1.19M to 0.51K | |
04-Feb-19 1:35 PM View: | EnteroMedics, Inc. (RSLS) | 31-Jan-19 | Private Purchase | 10,301 | $0.27 | $2,815.26 | < 1% 1.18M to 1.19M | (100%) |
31-Jan-19 10:43 AM View: | EnteroMedics, Inc. (RSLS) | 30-Jan-19 | Private Purchase | 48,000 | $0.28 | $13,440.00 | 4% 1.13M to 1.18M | (100%) |
31-Jan-19 10:43 AM View: | EnteroMedics, Inc. (RSLS) | 29-Jan-19 | Private Purchase | 12,200 | $0.28 | $3,390.38 | 1% 1.12M to 1.13M | (100%) |
28-Jan-19 3:46 PM View: | EnteroMedics, Inc. (RSLS) | 25-Jan-19 | Private Purchase | 15,595 | $0.27 | $4,237.16 | 1% 1.11M to 1.12M | (100%) |
28-Jan-19 3:46 PM View: | EnteroMedics, Inc. (RSLS) | 24-Jan-19 | Private Purchase | 6,190 | $0.25 | $1,578.45 | < 1% 1.1M to 1.11M | (100%) |
24-Jan-19 10:56 AM View: | EnteroMedics, Inc. (RSLS) | 22-Jan-19 | Private Purchase | 5,766 | $0.28 | $1,609.29 | < 1% 1.09M to 1.1M | (100%) |
22-Jan-19 9:39 AM View: | EnteroMedics, Inc. (RSLS) | 18-Jan-19 | Private Purchase | 24,334 | $0.28 | $6,786.75 | 2% 1.07M to 1.09M | (100%) |
22-Jan-19 9:39 AM View: | EnteroMedics, Inc. (RSLS) | 17-Jan-19 | Private Purchase | 52 | $0.28 | $14.56 | < 1% 1.07M to 1.07M | (100%) |
17-Jan-19 11:03 AM View: | EnteroMedics, Inc. (RSLS) | 16-Jan-19 | Private Purchase | 26,661 | $0.27 | $7,172.16 | 3% 1.04M to 1.07M | (100%) |
17-Jan-19 11:03 AM View: | EnteroMedics, Inc. (RSLS) | 15-Jan-19 | Private Purchase | 167,760 | $0.24 | $39,440.40 | 19% 875.65K to 1.04M | (100%) |
27-Apr-18 10:00 PM View: | Rosetta Genomics Ltd. (ROSGQ) | 26-Apr-18 | Purchase | 7,085 | $0.35 | $2,479.75 | < 1% 934.61K to 941.69K | |
19-Mar-18 9:40 AM View: | Rosetta Genomics Ltd. (ROSGQ) | 16-Mar-18 | Purchase | 64,298 | $0.43 | $27,728.20 | 7% 870.31K to 934.61K | |
16-Mar-18 10:28 AM View: | Rosetta Genomics Ltd. (ROSGQ) | 15-Mar-18 | Purchase | 46,570 | $0.42 | $19,574.10 | 6% 823.74K to 870.31K | |
16-Mar-18 10:28 AM View: | Rosetta Genomics Ltd. (ROSGQ) | 14-Mar-18 | Purchase | 73,191 | $0.42 | $30,816.70 | 10% 750.55K to 823.74K | |
14-Mar-18 3:42 PM View: | Rosetta Genomics Ltd. (ROSGQ) | 13-Mar-18 | Purchase | 37,319 | $0.42 | $15,683.30 | 5% 713.23K to 750.55K | |
14-Mar-18 3:42 PM View: | Rosetta Genomics Ltd. (ROSGQ) | 12-Mar-18 | Purchase | 138,509 | $0.42 | $57,661.70 | 24% 574.72K to 713.23K | |
17-Apr-14 4:17 PM View: | Akari Therapeutics Plc (AKTX) | 15-Apr-14 | Market Purchase | 17,100 | $5.00 | $85,500.00 | 2% 760.93K to 778.03K | (96%) |
17-Apr-14 4:17 PM View: | Akari Therapeutics Plc (AKTX) | 14-Apr-14 | Market Purchase | 3,000 | $5.21 | $15,630.00 | < 1% 757.93K to 760.93K | (96%) |
11-Apr-14 4:04 PM View: | Akari Therapeutics Plc (AKTX) | 11-Apr-14 | Market Purchase | 100 | $5.15 | $515.00 | < 1% 757.83K to 757.93K | (96%) |
11-Apr-14 4:04 PM View: | Akari Therapeutics Plc (AKTX) | 10-Apr-14 | Market Purchase | 1,400 | $5.25 | $7,350.00 | < 1% 756.43K to 757.83K | (96%) |
11-Apr-14 4:04 PM View: | Akari Therapeutics Plc (AKTX) | 09-Apr-14 | Market Purchase | 1,075 | $5.51 | $5,923.25 | < 1% 755.36K to 756.43K | (96%) |
08-Apr-14 4:05 PM View: | Akari Therapeutics Plc (AKTX) | 08-Apr-14 | Market Purchase | 35,500 | $5.36 | $190,280.00 | 5% 719.86K to 755.36K | (96%) |
08-Apr-14 4:05 PM View: | Akari Therapeutics Plc (AKTX) | 07-Apr-14 | Market Purchase | 20,654 | $5.71 | $117,840.00 | 3% 699.2K to 719.86K | (96%) |
08-Apr-14 4:05 PM View: | Akari Therapeutics Plc (AKTX) | 04-Apr-14 | Market Purchase | 12,250 | $6.07 | $74,400.00 | 2% 686.95K to 699.2K | (96%) |
02-Apr-14 4:04 PM View: | Akari Therapeutics Plc (AKTX) | 02-Apr-14 | Market Purchase | 2,500 | $6.15 | $15,375.00 | < 1% 1.35M to 1.36M | (97%) |
02-Apr-14 4:04 PM View: | Akari Therapeutics Plc (AKTX) | 01-Apr-14 | Market Purchase | 15,371 | $6.10 | $93,805.50 | 1% 1.34M to 1.35M | (96%) |
02-Apr-14 4:04 PM View: | Akari Therapeutics Plc (AKTX) | 31-Mar-14 | Market Purchase | 7,936 | $6.35 | $50,393.60 | < 1% 1.33M to 1.34M | (97%) |